Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anteris Technologies Ltd (OP:AMEUF)

5.700 UNCHANGED
Last Price Updated: 12:20 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Anteris Technologies Ltd

Anteris Technologies achieves breakthrough in triple valve replacement using DurAVR™
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) CEO Wayne Paterson sits down with Proactive’s Jonathan Jackson to discuss a complex 'valve-in-valve-in-valve' procedure completed using its DurAVR™... 
Via TheNewswire.com
News headline image
Anteris Technologies achieves breakthrough in triple valve replacement using DurAVR™
Anteris Technologies achieves breakthrough in triple valve replacement using DurAVR™ 
Via News Direct
Anteris talks market superiority of its biomimetic TAVR valve
--News Direct-- 
Via News Direct
Anteris talks market superiority of its biomimetic TAVR valve
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) CEO Wayne Paterson speaks with Proactive after the successful completion of enrolment for the company’s early feasibility study (EFS) to evaluate DurAVR™... 
Via TheNewswire.com
Anteris welcomes successful DurAVR valve-in-valve procedure
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) CEO Wayne Paterson tells Proactive the company’s flagship transcatheter heart valve has been successfully implanted during a valve-in-valve procedure as... 
Via TheNewswire.com
Anteris welcomes successful DurAVR valve-in-valve procedure
--News Direct-- 
Via News Direct
Anteris Technologies says latest first-in-human DurAVR™ results are next-level
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) CEO Wayne Paterson tells Proactive that new data from its first-in-human DurAVR™ transcatheter heart valve trial represent the best results to date at the... 
Via TheNewswire.com
News headline image
Anteris Technologies says latest first-in-human DurAVR™ results are next-level
Anteris Technologies says latest first-in-human DurAVR™ results are next-level 
Via News Direct
Anteris Technologies CEO talks A$35 million raise and 2023 milestones
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) CEO Wayne Paterson speaks with Proactive after announcing the company has secured A$35 million in funding from a placement to various sophisticated and... 
Via TheNewswire.com
News headline image
Anteris Technologies CEO talks A$35 million raise and 2023 milestones
Anteris Technologies CEO talks A$35 million raise and 2023 milestones 
Via News Direct
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.